Frontier Medicines is a biopharmaceutical company developing medicines to redefine the course of debilitating diseases. The company is using chemoproteomics to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development. Its chemoproteomics platform also integrates advanced computational approaches and machine learning to further accelerate the path to drug discovery.
|HQ||South San Francisco, US||Map|
|Employees (est.) (Nov 2019)||20|
Frontier Medicines total Funding
Frontier Medicines latest funding size
Time since last funding
|5 months ago|
Frontier Medicines investors
|MPM Capital, RA Capital Management, Deerfield, DROIA, Data Collective DCVC|
When was Frontier Medicines founded?
Frontier Medicines was founded in 2018.
Who are Frontier Medicines key executives?
Frontier Medicines's key executives are Chris Varma, Roberto Zoncu and Jim Winkler.
How many employees does Frontier Medicines have?
Frontier Medicines has 20 employees.
Who are Frontier Medicines competitors?
Competitors of Frontier Medicines include Biogen, MyoKardia and Otonomy.
Where is Frontier Medicines headquarters?
Frontier Medicines headquarters is located at 151 Oyster Point Blvd 2nd Floor, South San Francisco.
Where are Frontier Medicines offices?
Frontier Medicines has an office in South San Francisco.
How many offices does Frontier Medicines have?
Frontier Medicines has 1 office.
Receive alerts for 300+ data fields across thousands of companies